|
|
|
|
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
in00002434398 |
| 005 |
20190327171746.0 |
| 006 |
m d |
| 007 |
cr cn||||||||| |
| 008 |
080516s2008 enka sb 001 0 eng d |
| 020 |
|
|
|a 9780123705853
|
| 020 |
|
|
|a 0123705851
|
| 035 |
|
|
|a (OCoLC)ocn228148327
|
| 035 |
|
|
|a (OCoLC)228148327
|
| 037 |
|
|
|a 132123:132230
|b Elsevier Science & Technology
|n http://www.sciencedirect.com
|
| 040 |
|
|
|a OPELS
|c OPELS
|d UtOrBLW
|
| 049 |
|
|
|a TEFA
|
| 050 |
1 |
4 |
|a RE46
|b .O39 2008eb
|
| 082 |
0 |
4 |
|a 617.706
|2 22
|
| 245 |
0 |
0 |
|a Ocular therapeutics :
|b eye on new discoveries /
|c edited by Thomas Yorio, Abbot F. Clark, Martin B. Wax.
|
| 250 |
|
|
|a 1st ed.
|
| 264 |
|
1 |
|a Amsterdam ;
|a Boston ;
|a London :
|b Academic,
|c 2008.
|
| 300 |
|
|
|a xv, 520 pages :
|b illustrations ;
|c 27 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 533 |
|
|
|a Electronic reproduction.
|b Amsterdam :
|c Elsevier Science & Technology,
|d 2008.
|n Mode of access: World Wide Web.
|n System requirements: Web browser.
|n Title from title screen (viewed on May 14, 2008).
|n Access may be restricted to users at subscribing institutions.
|
| 520 |
|
|
|a Ocular Therapeutics: Eye on New Discovery focuses on emerging areas in ocular research, from new approaches to dry eye to gene therapy in the management of retinal diseases. This comprehensive book features more than 25 chapters of information that will be vital for ocular investigators and ophthalmologists bringing them new information on promising therapeutics. It is the intent of this book to provide not only information on current approaches to treatment, but also in giving the reader a greater understanding as to what may become available for treating a number of important eye diseases. Each chapter features some new aspect of treatment that holds great promise for the future. The approach has been to concentrate on those areas of ocular diseases that are more prevalent. It also features new insight for drug delivery and for managing devasting diseases, such as macula edema and glaucoma, two of the leading causes of blindness in the United States. This book will serve as an important resource as it contains a number of relevant references highlighted for their importance to the field. New investigators will be able to obtain an historical perspective for each of the topics and to develop an understanding of the new research directions that are underway. Ocular Therapeutics: Eye on New Discovery is more than a reference book, as it also provides an important glimpse into the near future. * Contains information that is vital for ocular investigators and ophthalmologists bringing them new information on promising therapeutics. * Provides not only information on current approaches to treatment, but also gives the reader a greater understanding as to what may become available for treating a number of important eye diseases. * Historical perspective for each of the topics as well as an important glimpse into the near future to develop an understanding of the new research directions underway. * New insight for drug delivery and for managing devastating diseases, such as macula edema and glaucoma, two of the leading causes of blindness in the United States.
|
| 505 |
0 |
|
|a Section I - General Principles and Therapeutic Targets -- Chapter 1: The Eye as Drug Target: Overview -- Chapter 2: Drug Delivery Systems in Ophthalmic Applications -- Chapter 3: IOP as a Target - Inflow and Outflow Pathways -- Chapter 4: The ciliary body: a potential multifaceted functional neuroendocrine unit. -- Chapter 5: Growth Factors and Neurotrophic Factors as Targets -- Section II. Visual Pathway -- Chapter 6: New therapies for Dry Eye Disease -- Chapter 7: Refractive Surgery: Corneal Opacity (haze) after Surface Ablation -- Chapter 8: Progress in Preventing Age-Related Cataract -- Chapter 9: Myopia Pharmacology: Etiologic Clues, Therapeutic Potential -- Section III. Inflammation, Immune System and Anti-infectives -- Chapter 10: Immune system and the eye -- Chapter 11: Ocular Allergy: Clinical, Therapeutic and Drug Discovery Considerations -- Chapter 12: Ocular Inflammation in Anterior Segment -- Chapter 13: Posterior Segment uveitis -- Chapter 14: New Anti-Infectives for Ophthalmology -- Section IV. Clinical Therapeutics -- Chapter 15: Tissue Repair and Regeneration -- Chapter 16: Therapeutic Drugs for Anterior Segment Ocular Surgery -- Chapter 17: Therapeutic Drugs for Posterior Segment Vitrectomy Surgery -- Chapter 18: Progress and Prospects in Ocular Gene Therapy -- Section V. Retinal Diseases and Neuropathies -- Chapter 19: Neuroprotection in Glaucoma -- Chapter 20: Degenerative Retinopathies -- Chapter 22: Ocular Angiogenesis.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g 1.
|t Eye as a drug target /
|r Thomas Yorio, Abbot F. Clark and Martin B. Wax --
|g 2.
|t drug delivery systems in ophthalmic applications /
|r Alan L. Weiner --
|g 3.
|t IOP as a target-inflow and outflow pathways /
|r Iok-Hou Pang and Abbot F. Clark --
|g 4.
|t Ciliary body: a potential multifaceted functional neuroendocrine unit /
|r Thomas Yorio, Ganesh Prasanna and Miguel Coca-Prados --
|g 5.
|t Growth factors and neurotrophic factors as targets /
|r Robert J. Wordinger and Abbot F. Clark --
|g 6.
|t New therapies for dry eye disease /
|r Gary N. Foulks --
|g 7.
|t Refractive surgery-corneal opacity (haze) after surface ablation /
|r Steven E. Wilson and Fabricio W. Medeiros --
|g 8.
|t Progress in preventing age-related cataract /
|r David C. Beebe and Ying-Bo Shui --
|g 9.
|t Myopia pharmacology: etiologic clues, therapeutic potential /
|r Richard A. Stone --
|g 10.
|t Immune system and the eye /
|r Jerry Y. Niederkorn and M. Reza Dana --
|g 11.
|t Ocular allergy: clinical, therapeutic and drug discovery considerations /
|r John M. Yanni and Neal P. Barney --
|g 12.
|t Ocular inflammation in anterior segment /
|r Shlomit Schaal and Henry Kaplan --
|g 13.
|t Posterior segment uveitis /
|r Russell N. Van Gelder --
|g 14.
|t New anti-infectives for ophthalmology /
|r Barry A. Schlech --
|g 15.
|t Tissue repair and regeneration /
|r Peng Tee Khaw et al --
|g 16.
|t Therapeutic drugs for anterior segment ocular surgery /
|r Malik Y. Kahook and Joel S. Schuman --
|g 17.
|t Therapeutic agents for posterior segment vitrectomy surgery /
|r Lucian V. Del Priore, Henry J. Kaplan and Tongalp H. Tezel --
|g 18.
|t Progress and prospects in ocular gene therapy /
|r Xuyang Liu, Carol A. Rasmussen, Jean Bennett, Curtis R. Brandt, B'Ann T. Gabelt, Paul L. Kaufman --
|g 19.
|t Neuroprotection in glaucoma /
|r Joseph Caprioli and Natik Piri --
|g 20.
|t Degenerative retinopathies /
|r Gerald J. Chader --
|g 21.
|t Ocular angiogenesis /
|r Jing Chen and Lois E.H. Smith.
|
| 500 |
|
|
|a Electronic resource.
|
| 650 |
|
0 |
|a Eye
|x Diseases
|x Treatment.
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 700 |
1 |
|
|a Yorio, Thomas.
|
| 700 |
1 |
|
|a Clark, Abbot F.
|
| 700 |
1 |
|
|a Wax, Martin B.
|
| 776 |
1 |
|
|c Original
|z 9780123705853
|z 0123705851
|w (OCoLC)155678425
|
| 710 |
2 |
|
|a ScienceDirect (Online service)
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=http://www.sciencedirect.com/science/book/9780123705853
|z Connect to the full text of this electronic book
|t 0
|
| 994 |
|
|
|a C0
|b TEF
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 2b98777b-372c-3f8a-8447-af62b8991e69
|i 4e54ed31-a2f9-3615-9912-12841053af1a
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e RE46 .O39 2008eb
|h Library of Congress classification
|
| 998 |
f |
f |
|a RE46 .O39 2008eb
|t 0
|l Available Online
|